31 related articles for article (PubMed ID: 10232320)
1. Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy.
Wang W; Liu W; Zhang N; He X
Oncol Lett; 2018 Oct; 16(4):4879-4888. PubMed ID: 30250554
[TBL] [Abstract][Full Text] [Related]
2. Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.
Yang J; Dombrowski SM; Deshpande A; Krajcir N; El-Khoury S; Krishnan C; Luciano MG
Neurochem Res; 2011 Nov; 36(11):1947-54. PubMed ID: 21643730
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin 1 expression and angiogenesis in breast carcinoma and their relation with platelet activity.
Tokyol C; Ersoz G; Dilek FH; Gencer E; Kosar MN; Dilek ON
Ups J Med Sci; 2009; 114(2):108-15. PubMed ID: 19396698
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Tsimafeyeu IV; Demidov LV; Madzhuga AV; Somonova OV; Yelizarova AL
J Exp Clin Cancer Res; 2009 Mar; 28(1):30. PubMed ID: 19254383
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.
Feldman DR; Baum MS; Ginsberg MS; Hassoun H; Flombaum CD; Velasco S; Fischer P; Ronnen E; Ishill N; Patil S; Motzer RJ
J Clin Oncol; 2009 Mar; 27(9):1432-9. PubMed ID: 19224847
[TBL] [Abstract][Full Text] [Related]
6. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
Shimanuki Y; Takahashi K; Cui R; Hori S; Takahashi F; Miyamoto H; Fukurchi Y
Lung; 2005; 183(1):29-42. PubMed ID: 15793665
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.
Jubb AM; Pham TQ; Hanby AM; Frantz GD; Peale FV; Wu TD; Koeppen HW; Hillan KJ
J Clin Pathol; 2004 May; 57(5):504-12. PubMed ID: 15113858
[TBL] [Abstract][Full Text] [Related]
8. A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?
Hormbrey E; Gillespie P; Turner K; Han C; Roberts A; McGrouther D; Harris AL
Clin Exp Metastasis; 2002; 19(8):651-63. PubMed ID: 12553370
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis is an independent prognostic factor in malignant mesothelioma.
Edwards JG; Cox G; Andi A; Jones JL; Walker RA; Waller DA; O'Byrne KJ
Br J Cancer; 2001 Sep; 85(6):863-8. PubMed ID: 11556838
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice.
Kanayama H; Yano S; Kim SJ; Ozawa S; Ellis LM; Fidler IJ
Clin Exp Metastasis; 1999; 17(10):831-40. PubMed ID: 11089881
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas.
Mineta H; Miura K; Ogino T; Takebayashi S; Misawa K; Ueda Y; Suzuki I; Dictor M; Borg A; Wennerberg J
Br J Cancer; 2000 Sep; 83(6):775-81. PubMed ID: 10952783
[TBL] [Abstract][Full Text] [Related]
12. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients.
O'Byrne KJ; Dobbs N; Harris AL
Br J Cancer; 2000 Jun; 82(11):1895-6. PubMed ID: 10839310
[No Abstract] [Full Text] [Related]
13. Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma.
Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B
Eur J Cancer Prev; 2002 Jun; 11(3):245-52. PubMed ID: 12131658
[TBL] [Abstract][Full Text] [Related]
14. [VEGF (vascular endothelial growth factor)].
Hayashi K
Nihon Rinsho; 1999 Nov; 57 Suppl():805-7. PubMed ID: 10635975
[No Abstract] [Full Text] [Related]
15. Prognostic factors in acute myelogenous leukemia.
Estey EH
Leukemia; 2001 Apr; 15(4):670-2. PubMed ID: 11368376
[No Abstract] [Full Text] [Related]
16. Vascular endothelial growth factor platelet counts, and prognosis in renal cancer.
O'Byrne KJ; Dobbs N; Propper D; Smith K; Harris AL
Lancet; 1999 May; 353(9163):1494-5. PubMed ID: 10232320
[No Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor platelet counts and renal cancer.
Gunsilius E; Petzer AL; Gastl G
Lancet; 1999 Jun; 353(9171):2247. PubMed ID: 10393017
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
